Dr. Hiremath is a board certified pediatric gastroenterologist with a broad background in epidemiology, biostatistics, research methods, and biomedical imaging. He leads the pediatric Eosinophilic Gastrointestinal Disorders clinic at Vanderbilt. This multi-disciplinary clinic focuses on providing exceptional clinical care to individuals with eosinophilic gastrointestinal diseases and also allows him to conduct patient-oriented research.
Through his research, Dr. Hiremath aims to positively impact care and promote clinical outcomes of individuals affected by eosinophilic gastrointestinal diseases. At Vanderbilt, he has developed an interdisciplinary approach to address some of the outstanding questions in the field of eosinophilic esophagitis. Specifically, his research program focuses on the epidemiology, pathogenesis, diagnosis, and management of this onerous condition. Using his prior training and experiences he is delving into the epidemiology of eosinophilic esophagitis and eosinophilic gastrointestinal diseases. Through his secondary appointment in the Vanderbilt School of Biomedical Engineering he is applying advanced biomedical technologies to gain novel insights into the pathogenesis and molecular mechanisms underlying the development and progression of eosinophilic esophagitis.
Dr. Hiremath has been conducting eosinophilic gastrointestinal diseases research for more than a decade. He has collaborations with clinicians and scientists within the Vanderbilt University and with experts all across the world. His single minded devotion to the field has been recognized by his peers through his nomination to the Society for Pediatric Research. He has received several awards including the NIH K12, NIH Training grant (T32), the Consortium of Eosinophilic Gastrointestinal Disease Researchers training award, and the American College of Gastroenterology Junior Faculty Development award.
PRODUCED IN CONJUNCTION WITH KNIGHTEN HEALTH